抗抑郁药和低血的风险:一个使用观察医学结果的多机构队列研究伙伴关系-共同数据模型
Kyungyeon Jung1, Ju Hwan Kim1,2, Da Eun Hyeon3
1Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
British journal of clinical pharmacology
|January 14, 2026
概括
选择性血红素再吸收抑制剂 (SSRI) 增加了低血的风险,特别是在老年人中. 对使用SSRI的患者,尤其是60岁及以上的患者来说,血清的监测至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 流行病学 流行病学
背景情况:
- 低血是与抗抑郁药物使用相关的频繁且严重的不良事件.
- 鉴定低血症风险的抗抑郁药对患者安全至关重要.
研究的目的:
- 为了比较不同类型抗抑郁药的低血症风险.
- 确定哪种抗抑郁药类对发展低血症的风险最小.
主要方法:
- 一项使用15家医院 (2003-2023) 电子病历的回顾性队列研究.
- 分析了开始服用选择性血红素再吸收抑制剂 (SSRI),血红素 - 上腺素再吸收抑制剂 (SNRIs),三环抗抑郁药 (TCA) 或其他抗抑郁药的患者.
- 发病后180天内发生的低血是主要结果,评估时使用倾向分数分层化后的考克斯回归.
主要成果:
- 选择性血红素再吸收抑制剂 (SSRI) 与180天内的低血风险增加有关 (HR 1.18,95% CI 1.01-1.38).
- 60岁及以上开始使用SSRI的患者的风险更高 (HR 1.29,95% CI 1.06-1.57).
- 对于SNRIs,TCAs或其他抗抑郁药类药物,没有发现显著的低血风险.
结论:
- 选择性血红素再吸收抑制剂 (SSRI) 需要密切监测低血,特别是在老年患者 (≥60岁).
- 进一步的研究可能会探索SSRI诱导的低血症的机制和预防策略.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
521
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.5K
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806
01:25Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
01:18Depression: Overview
777
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
777
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.4K
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
465
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
465